Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 106.00
-0.64 (-0.60%)
Jul 16, 2025, 3:29 PM IST
Ind-Swift Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Operating Revenue | 4,471 | 12,809 | 12,073 | 10,387 | 8,913 | 7,796 | Upgrade |
Other Revenue | 163.66 | 163.66 | 86.24 | 141.74 | 154.32 | 197.04 | Upgrade |
| 4,635 | 12,973 | 12,159 | 10,529 | 9,068 | 7,993 | Upgrade | |
Revenue Growth (YoY) | -61.39% | 6.69% | 15.48% | 16.11% | 13.44% | 2.61% | Upgrade |
Cost of Revenue | 2,412 | 6,615 | 6,556 | 5,374 | 4,514 | 3,967 | Upgrade |
Gross Profit | 2,223 | 6,358 | 5,604 | 5,155 | 4,553 | 4,027 | Upgrade |
Selling, General & Admin | 632.57 | 1,582 | 1,401 | 1,278 | 1,079 | 1,058 | Upgrade |
Other Operating Expenses | 1,045 | 2,092 | 1,814 | 1,642 | 1,492 | 1,328 | Upgrade |
Operating Expenses | 1,811 | 4,208 | 3,788 | 4,231 | 3,444 | 3,287 | Upgrade |
Operating Income | 411.98 | 2,150 | 1,815 | 924.23 | 1,110 | 739.6 | Upgrade |
Interest Expense | - | -466.94 | -863.93 | -914.53 | -933.53 | -1,025 | Upgrade |
Interest & Investment Income | 335.6 | 183.71 | 58.72 | 5.62 | 5.13 | 5.3 | Upgrade |
Earnings From Equity Investments | -0.98 | -4.9 | -2.34 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 105.52 | 105.52 | 180.87 | 147.63 | 32.72 | 137.58 | Upgrade |
Other Non Operating Income (Expenses) | 135.09 | -43.32 | -48.57 | 99.03 | -33.83 | -56.22 | Upgrade |
EBT Excluding Unusual Items | 987.2 | 1,924 | 1,140 | 261.99 | 180.09 | -198.36 | Upgrade |
Gain (Loss) on Sale of Assets | 22.35 | 22.35 | -0.61 | -65.66 | - | 0.65 | Upgrade |
Asset Writedown | - | - | -10 | -71.01 | - | - | Upgrade |
Other Unusual Items | 3,866 | 3,866 | -266.48 | - | - | - | Upgrade |
Pretax Income | 4,875 | 5,813 | 862.87 | 125.33 | 180.09 | -197.71 | Upgrade |
Income Tax Expense | 1,335 | 1,603 | 386.9 | 146.82 | 211.56 | 14.17 | Upgrade |
Net Income | 3,540 | 4,210 | 475.97 | -21.49 | -31.47 | -211.88 | Upgrade |
Net Income to Common | 3,540 | 4,210 | 475.97 | -21.49 | -31.47 | -211.88 | Upgrade |
Net Income Growth | 719.54% | 784.44% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 59 | 59 | 59 | 59 | 59 | 49 | Upgrade |
Shares Outstanding (Diluted) | 59 | 59 | 59 | 59 | 59 | 49 | Upgrade |
Shares Change (YoY) | -0.26% | - | - | - | 19.46% | -9.47% | Upgrade |
EPS (Basic) | 60.05 | 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | Upgrade |
EPS (Diluted) | 60.05 | 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | Upgrade |
EPS Growth | 721.63% | 784.38% | - | - | - | - | Upgrade |
Free Cash Flow | - | -2,076 | 1,818 | 1,319 | 1,310 | 1,145 | Upgrade |
Free Cash Flow Per Share | - | -35.14 | 30.78 | 22.32 | 22.18 | 23.15 | Upgrade |
Gross Margin | 47.97% | 49.01% | 46.08% | 48.96% | 50.21% | 50.38% | Upgrade |
Operating Margin | 8.89% | 16.58% | 14.93% | 8.78% | 12.24% | 9.25% | Upgrade |
Profit Margin | 76.38% | 32.45% | 3.91% | -0.20% | -0.35% | -2.65% | Upgrade |
Free Cash Flow Margin | - | -16.00% | 14.95% | 12.52% | 14.45% | 14.32% | Upgrade |
EBITDA | 914.33 | 2,683 | 2,389 | 2,235 | 1,983 | 1,640 | Upgrade |
EBITDA Margin | 19.73% | 20.68% | 19.64% | 21.22% | 21.86% | 20.52% | Upgrade |
D&A For EBITDA | 502.35 | 532.8 | 573.39 | 1,310 | 872.92 | 900.59 | Upgrade |
EBIT | 411.98 | 2,150 | 1,815 | 924.23 | 1,110 | 739.6 | Upgrade |
EBIT Margin | 8.89% | 16.58% | 14.93% | 8.78% | 12.24% | 9.25% | Upgrade |
Effective Tax Rate | 27.39% | 27.58% | 44.84% | 117.15% | 117.48% | - | Upgrade |
Revenue as Reported | 5,103 | 13,263 | 12,408 | 10,822 | 9,140 | 8,130 | Upgrade |
Advertising Expenses | - | 45.55 | 34.92 | 2.36 | 7.66 | 22.92 | Upgrade |
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.